mp-757261: Fe2Co(PO4)3 (Trigonal, R-3c, 167)
Fe₂Co(PO₄)₃ crystallizes in the trigonal R̅3c space group. Fe³⁺ is bonded to six O²⁻ atoms to form distorted FeO₆ octahedra that share corners with six equivalent PO₄ tetrahedra and a faceface with one CoO₆ octahedra. There are three shorter (1.93 Å) and three longer (2.10 Å) Fe-O bond lengths. Co³⁺ is bonded to six equivalent O²⁻ atoms to form distorted CoO₆ octahedra that share corners with six equivalent PO₄ tetrahedra and faces with two equivalent FeO₆ octahedra. All Co-O bond lengths are 2.10 Å. P⁵⁺ is bonded to four O²⁻ atoms to form PO₄ tetrahedra that share corners with two equivalent CoO₆ octahedra and corners with four equivalent FeO₆ octahedra. The corner-sharing octahedral tilt angles range from 29-53°. There are two shorter (1.52 Å) and two longer (1.57 Å) P-O bond lengths. There are two inequivalent O²⁻ sites. In the first O²⁻ site, O²⁻ is bonded in a bent 150 degrees geometry to one Fe³⁺ and one P⁵⁺ atom. In the second O²⁻ site, O²⁻ is bonded in a 3-coordinate geometry to one Fe³⁺, one Co³⁺, and one P⁵⁺ atom.
RCSB PDB - 4I3R: Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P3221
312619-41-3 Iron(III) p-toluenesulfonate hexahydrate AKSci P254
mp-757261: Fe2Co(PO4)3 (trigonal, R-3c, 167)
Trigonal crystal structure (space group R ¯ 3c, No. 167) of the weak
File:Tu-142M&P-3C-Orion-1986-DN-SC-87-00265.jpg - Wikipedia
937263-43-9, N4-(4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine
mp-1147553: KCuIO6 (Trigonal, P312, 149)
RCSB PDB - 4I3R: Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P3221
RCSB PDB - 4I3R: Crystal structure of the outer domain of HIV-1 gp120 in complex with VRC-PG04 space group P3221
mp-1206553: Rb2LiRuCl6 (Trigonal, P-3m1, 164)
mp-1176491: MgSnO3 (Trigonal, R-3, 148)
mp-14012: Cu3P (Trigonal, P-3c1, 165)
Chemokine receptor co-expression reveals aberrantly distributed TH effector memory cells in GPA patients, Arthritis Research & Therapy
FT159110, 3779-63-3
260367-81-5, MFCD01314401, 2-methyl-1-{4-[3-(trifluoromethyl)pyridin-2-yl]piperazino}propan-1-one